ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FARN Faron Pharmaceuticals Oy

150.00
0.00 (0.00%)
Last Updated: 07:44:03
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Faron Pharmaceuticals Oy LSE:FARN London Ordinary Share FI4000153309 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 150.00 140.00 160.00 150.00 150.00 150.00 50 07:44:03
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -28.73M -0.4177 -3.59 103.18M
Faron Pharmaceuticals Oy is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FARN. The last closing price for Faron Pharmaceuticals Oy was 150p. Over the last year, Faron Pharmaceuticals Oy shares have traded in a share price range of 117.50p to 360.00p.

Faron Pharmaceuticals Oy currently has 68,786,699 shares in issue. The market capitalisation of Faron Pharmaceuticals Oy is £103.18 million. Faron Pharmaceuticals Oy has a price to earnings ratio (PE ratio) of -3.59.

Faron Pharmaceuticals Oy Share Discussion Threads

Showing 226 to 250 of 1625 messages
Chat Pages: Latest  17  16  15  14  13  12  11  10  9  8  7  6  Older
DateSubjectAuthorDiscuss
10/5/2018
11:28
How when my average is £1.10 on 30k shares loooool
kirk 6
10/5/2018
10:54
Looks like a bunch of Gamblers gonna get spiked here, MM's laughing
boxerdogz
10/5/2018
10:32
I bought some IMM today!!!! STILL HOLDING FARN...Expecting some profiting taking but im in this for long term. 1 years plus!
jayj4u
10/5/2018
10:28
Further investigations are currently underway to provide additional information on the outcome of the current analysis
hope67
10/5/2018
10:28
They seem surprised by the results compared to other studies

Dr Markku Jalkanen, CEO of Faron, said: "We are incredibly disappointed and surprised by these results. We need to further analyse the data in order to understand how this study differs from our previous positive results with ARDS patients, both in terms of Traumakine's efficacy, and in the unusually low mortality rate observed in the placebo arm. We look forward to the results of the Japanese study in Q3 2018 and will be considering how we can advance Traumakine in clinical development.



"We will continue our plans to advance our next asset, Clevegen, our second candidate which is a ground breaking anti-Clever-1 antibody, into clinical development in solid cancers later this year.

hope67
10/5/2018
09:17
Short squeeze.. Should break 200p easy at this rate
letmepass
10/5/2018
09:05
NT to buy..proving difficult to get stock here
pre
10/5/2018
09:04
I'm thinking this could hit 600p before that with a director buy as well.. All speculation of course
shirley83
10/5/2018
09:03
True.. Difficult to predict but they can have another go in Japan.. Maybe it works?
shirley83
10/5/2018
09:00
Shirley8310 - "Well done Pwhite but pharma stocks you have no clue about.."

And neither does this company after what has happened of late.

pwhite73
10/5/2018
08:53
Short squeeze this could hit 600p
shirley83
10/5/2018
08:51
Come to daddy
kirk 6
10/5/2018
08:49
NT to buy...get ready...
pre
10/5/2018
08:46
Squeeze coming as mms run short
shirley83
10/5/2018
08:45
Yes, anyone who bought them at around £1... has made over 60%! But I'm waiting for much more...I think minimum £2 by this week!!
jayj4u
10/5/2018
08:44
Well done Pwhite but pharma stocks you have no clue about..
shirley83
10/5/2018
08:43
Every stock is different. This has another 3p... even the yesterday news I treat cautiously.
jayj4u
10/5/2018
08:42
should see a break past £1.70 shortly...
pre
10/5/2018
08:42
inv - "should be 300p plus on Japanese news"

The Japanese study would have used the same methodology as the US/European study. Even if they came out positive. Phase III has still failed.

pwhite73
10/5/2018
08:38
IMM initially bounced it is now trading at its lowest ever. The same will happen to this stock when the shorts and longs have finished battling it out. The stock is rising to burn the shorts still open from the initial drop. The TR1 yesterday was Polar Capital reducing its holding.
pwhite73
10/5/2018
08:34
should be 3oop plus on Japanese news
inv
10/5/2018
08:33
This drop is way over done! I'm in at £1.45... looking for £2.30-£2.50 plus... I might just hold for next p3!
jayj4u
10/5/2018
08:32
Thinking 300p easy.. Way oversold and more to come
shirley83
10/5/2018
08:29
Looks like +£2 likely here...NT to buy and big squeeze on the way?
pre
10/5/2018
07:47
Hopefully a nice steady rise.. Way oversold with so much in the pipeline.. Read the RNS
shirley83
Chat Pages: Latest  17  16  15  14  13  12  11  10  9  8  7  6  Older

Your Recent History

Delayed Upgrade Clock